Vericel Corp (VCEL)
47.77
-1.79
(-3.61%)
USD |
NASDAQ |
May 08, 16:00
47.77
0.00 (0.00%)
After-Hours: 20:00
Vericel Stock Buybacks (Quarterly): -1.386M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.386M |
September 30, 2023 | -1.116M |
June 30, 2023 | -1.273M |
March 31, 2023 | -2.225M |
December 31, 2022 | -0.612M |
September 30, 2022 | -0.829M |
June 30, 2022 | -0.746M |
March 31, 2022 | -1.465M |
December 31, 2021 | -1.483M |
September 30, 2021 | -2.08M |
June 30, 2021 | -3.84M |
March 31, 2021 | -3.781M |
December 31, 2020 | -4.45M |
September 30, 2020 | -2.182M |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.062M |
June 30, 2018 | -70.09M |
March 31, 2018 | |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 0.302M |
September 30, 2014 | -41.32M |
June 30, 2014 | -3.462M |
March 31, 2014 | -5.455M |
December 31, 2013 | -1.59M |
September 30, 2013 | -10.47M |
June 30, 2013 | 0.00 |
March 31, 2013 | -2.378M |
December 31, 2012 | 0.00 |
September 30, 2012 | -0.17M |
June 30, 2012 | 0.00 |
March 31, 2012 | -0.176M |
December 31, 2011 | 0.00 |
September 30, 2011 | -0.015M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-4.45M
Minimum
Dec 2020
-0.612M
Maximum
Dec 2022
-1.962M
Average
-1.474M
Median
Stock Buybacks (Quarterly) Benchmarks
ANI Pharmaceuticals Inc | 0.231M |
Arbutus Biopharma Corp | -21.76M |
Chimerix Inc | -- |
Karyopharm Therapeutics Inc | 0.00 |
Y-mAbs Therapeutics Inc | -- |